Table 2.
Lipid fraction |
Risk of coronary artery disease: genetic estimate |
Risk of coronary artery disease: RCT evidence |
Risk of type 2 diabetes: genetic estimate |
Risk of type 2 diabetes: RCT evidence |
---|---|---|---|---|
Lower LDL cholesterol | Reduced[26–28] | Reduced[6, 23] | Increased[39, 40] | Increased[37] |
Higher HDL cholesterol | Null[26–28] | Null[46–49] | Reduced[40] | No evidence |
Lower Triglycerides | Reduced[25, 26] | No direct evidence but some indirect evidence for reduced risk[50] | Reduced[40] | No evidence |
LDL = low-density lipoproteins; HDL = high-density lipoproteins; Genetic estimate refers to Mendelian randomization studies including multiple genetic variants affecting the trait; RCT evidence = results from randomized control trials of drugs focused primarily on modifying that lipid trait.